Treating To Target Post Methotrexate: New Horizons in RA Therapy From the 2017 ACR/ARHP Annual Meeting
| Overview / Abstract: |
This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interleukin-6 (IL-6) or members of the Janus kinase (JAK) family of enzymes. Some of the modules also include 3D-animated elements to illustrate the relationships between the heterogeneous pathophysiologic mechanisms underlying RA and certain targeted biologic or synthetic disease-modifying treatment options. |
|
Expiration |
Feb 28, 2019 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
|
Format |
Online, Seminar, Webinar / Webcast / Video |
|
Credits / Hours |
0.25 |
|
Accreditation |
ACCME, CE |
|
Presenters / Authors / Faculty |
Leonard H. Calabrese, DO; John R.P. Tesser, MD |
|
Sponsors / Supporters / Grant Providers |
This activity has been supported by independent educational grants from Gilead Sciences, Inc., and Sanofi Genzyme and Regeneron Pharmaceuticals and jointly provided by the Elsevier Office of Continuing Medical Education and Integritas Communications. |
|
Keywords / Search Terms |
Integritas Communications, Methotrexate, RA, JAK, Janus kinase, rheumatoid arthritis, clinicians, CME, Free CME, CE, Free CE, CME Snapshot, video, webcast, Calabrese, Tesser, interleukin-6, IL-6 |
|